ArticleMolecular therapy. Nucleic acids2018

Transient Retrovirus-Based CRISPR/Cas9 All-in-One Particles for Efficient, Targeted Gene Knockout.

Yvonne Knopp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.